CACNA1C and Timothy syndrome: The therapeutic use of calcium channel blockers, such as dihydropyridines (DHPs) and verapamil, in TS has been an area of interest given their potential to attenuate the increased calcium influx caused by dysfunctional CaV1.2 channels.